Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Antegrade Balloon Aortic Valvuloplasty for the Highly Frail Patient of Severe Aortic Stenosis Complicated with Transthyretin-type Cardiac Amyloidosis
Shohei YoshidaHayato TadaTetsuo NishikawaTamami Nakagawa-KamiyaTakuya NakahashiKenji SakaiKenji SakataMasa-aki KawashiriMasahito YamadaMasayuki Takamura
Author information
JOURNAL OPEN ACCESS

2020 Volume 59 Issue 8 Pages 1053-1057

Details
Abstract

Transcatheter aortic valve implantation (TAVI) is widely accepted as the treatment for patient with severe aortic stenosis (AS) whose prognosis may be over one year; however, there is no consensus concerning extremely high-risk patients whose prognosis may not exceed one year. We herein report a highly frail patient with severe AS complicated with transthyretin-type cardiac amyloidosis who had a very poor prognosis. Given his condition, we treated him by percutaneous antegrade balloon aortic valvuloplasty (A-BAV) instead of TAVI. A-BAV may be a beneficial option for treating extremely high-risk severe AS patients, including those with cardiac amyloidosis.

Content from these authors
© 2020 by The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top